Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis.

MLA

Loregger, Anke, et al. “Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis.” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 37, no. 11, Nov. 2017, pp. 2064–74. EBSCOhost, https://doi.org/10.1161/ATVBAHA.117.310002.

APA

Loregger, A., Raaben, M., Tan, J., Scheij, S., Moeton, M., van den Berg, M., Gelberg-Etel, H., Stickel, E., Roitelman, J., Brummelkamp, T., & Zelcer, N. (2017). Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 37(11), 2064–2074. https://doi.org/10.1161/ATVBAHA.117.310002

Chicago

Loregger, Anke, Matthijs Raaben, Josephine Tan, Saskia Scheij, Martina Moeton, Marlene van den Berg, Hila Gelberg-Etel, et al. 2017. “Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis.” Arteriosclerosis, Thrombosis, and Vascular Biology 37 (11): 2064–74. doi:10.1161/ATVBAHA.117.310002.